Net Cash Provided by (Used in) Financing Activities of INSMED Inc from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
INSMED Inc annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • INSMED Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $28,998,000, a 860% increase year-over-year.
  • INSMED Inc annual Net Cash Provided by (Used in) Financing Activities for 2025 was $954,073,000, a 29% decline from 2024.
  • INSMED Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,341,020,000, a 696% increase from 2023.
  • INSMED Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $168,439,000, a 79% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

INSMED Inc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $954,073,000 -$386,947,000 -29% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $1,341,020,000 +$1,172,581,000 +696% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $168,439,000 -$624,834,000 -79% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
2022 $793,273,000 +$180,727,000 +30% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
2021 $612,546,000 +$341,543,000 +126% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $271,003,000 -$14,275,000 -5% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $285,278,000 -$101,465,000 -26% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2022 2021 FY
2018 $386,743,000 +$5,654,000 +1.5% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $381,089,000 +$350,416,000 +1142% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $30,673,000 -$197,131,000 -87% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $227,804,000 01 Jan 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
2012 $45,424,000 +$45,474,000 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2013 2012 FY
2011 $50,000* +$183,000 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2013 2012 FY
2010 $233,000 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013 2012 FY

INSMED Inc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $28,998,000 +$25,976,000 +860% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $3,022,000 +$3,421,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $399,000 -$6,858,000 -106% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $6,459,000 -$244,000 -3.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $6,703,000 +$4,569,000 +214% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $2,134,000 -$915,000 -30% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $3,049,000 -$375,117,000 -99% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q1 2018 $378,166,000 +$377,601,000 +66832% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $565,000 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2012 $34,000,000 -$33,979,000 01 Jan 2012 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q1 2011 $21,000* 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.